NIST Advanced Technology Program
Return to ATP Home Page
ATP Historical Award Statistics Business Reporting System Surveys EAO Economic Studies and Survey Results ATP Factsheets EAO Home Page

NISTIR 6917
Different Timelines for Different Technologies:
Evidence from the Advanced Technology Program

VII. Summary of Findings by Technology Area, Conclusion, and Future Work

A summary of findings presents the results of the factor analysis presented in Section VI in the context of the life-cycle framework. We conclude with policy implications and plans for future work.

A. Summary of Findings by Technology Area, Conclusion, and Future Work

Some of the key findings, by technology area, are as follows:

Biotechnologies and Information Technologies
Biotechnologies and information technologies support a host of new-to-the-world applications in a number of industries. They support formation of new industries.

Information technologies enter the market quickly, with a significant percentage of applications expecting commercialization during the period of ATP funding, and with nearly two-thirds expecting commercialization by a year later. For half of IT applications, the window of market opportunity is expected to close within a year after ATP funding ends. This timeline is consistent with the rapid pace of the early phase of the innovation life cycle for small firms competing to open and capture new markets. Service applications can be important commercialization strategies as an initial point of market entry to end users in many industries, as a more primary mechanism for technology advancement in mature manufacturing industries, and as a strategy for addressing growth industries like health care and telecommunications services.

Biotechnology projects have a number of early opportunities for service applications (for example, research and testing services) that are useful for market conditioning and validation. That is the case even if biotech applications do not generate large cash flows or economic impact in therapeutic markets until much later.

Regulatory requirements prohibit fast market entry for many health care applications. The market is expected to remain open for major applications for more than five years after ATP funding ends.

  • The innovation focus is on achieving basic functionality and performance of new-to-the-world products.
  • The flow of investment capital suggests investors envision the broad future potential of the markets expected to emerge.
  • The precise nature of the larger markets and distribution mechanisms is still blurred.
  • Technology-based competition is keen, and dominance changes rapidly in new and emerging markets.

Manufacturing and Materials-Chemistry Projects
Manufacturing and materials-chemistry projects more typically are developing new process technologies for existing classes of products in mature, commodity-oriented industries. Manufacturing technologies and materials-chemistry technologies commercialize slowly; however, opportunities are expected to accelerate about two years after ATP funding ends and then to decline relatively slowly compared with other technologies.

  • The focus is on manufacturability and cost to gain advantage in “cents per pound,” high-volume markets, as well as on higher performance products.
  • Capital investment and validation requirements are costly and lengthy. Financing typically comes from retained earnings.
  • Product life cycles and market windows are longer than for IT or electronics projects. Technological change occurs more slowly than in new product areas, particularly for commodity types of products.
  • Joint ventures are an important vehicle for sharing risks and technological uncertainties, particularly in addressing interdisciplinary issues where different technologies converge, such as information technology for manufacturing or healthcare applications or many electronics/photonics projects that involve a mix of materials, electronics, and manufacturing issues.

Electronics
Electronics (and related materials) projects tend to involve a mix of new and established firms in transitional, rapid-growth stages of innovation, company, and industry development.

  • Product applications are more common than process applications.
  • Cost and manufacturability are critical objectives.
  • Electronics product markets are extremely competitive; product life cycles are short; and capital requirements for high-volume production remain steep barriers to market entry.
  • Nearly three-fourths of applications are expected to earn revenues within two years after ATP funding ends. Windows of market opportunity are expected to diminish quickly after two years.

B. Conclusion and Policy Implications

The innovation life-cycle model provides a useful framework for illuminating differences in commercialization patterns across ATP-funded technology areas. Our analysis shows that characteristics such as speed to market, size of firm, project structure, commercialization strategy, and technology area map to most features and stages of the innovation life cycle summarized in Table 1. This innovation life-cycle framework provides a general trajectory of what to expect when and under what circumstances for future use in project selection and assessment of project performance. For example, credible and appropriate commercialization plans and expectations about revenue must be expected to vary by technology area, consistent with the analysis presented in this study. Project proposals that indicate pathways to markets with major deviations from this analytical framework need to be examined before funding is committed.

C. Future Work

The data on timing of commercialization and windows of market opportunity used in the body of the study reflect expectations at the time of the last report on file from each ATP project participant, rather than actual commercialization history. This study initiated a further effort to compare actual commercialization histories of ATP-funded technologies against expectations. These analyses are presented in the Appendix.

Data presented in the Appendix from Close-out Reports for a large portion of the project participants covered in the body of the study suggest that ATP projects are meeting or exceeding expectations for their earliest commercial applications. Data from Post-project Surveys conducted two to three years after the end of ATP funding suggest that the commercialization pace may have slowed down relative to expectations by that time.

Given the small number of Close-out and Post-project reports available from each technology area, their analysis must be judged to be preliminary. Additional data and analysis by type of commercial application, by technology area, and by type of ATP project and role within the project are needed to document the longer-term history and to identify characteristics of success and failure to meet expectations.

This study is the first of many anticipated studies that characterize the differences in commercialization patterns of different ATP-funded technologies. The growing number of Post-project Surveys provide substantial data documenting the actual performance of projects against plans over longer portions of the technology life cycle. Future studies will analyze ATP-funded innovation by specific industry-use sectors and areas of technology impact as well as core technology area.

Return to Table of Contents or go to Appendix. Actual versus Expected Commercialization Timelines: Preliminary Results

Date created: March 4, 2003
Last updated: April 12, 2005

Return to ATP Home Page

ATP website comments: webmaster-atp@nist.gov  / Technical ATP inquiries: InfoCoord.ATP@nist.gov

NIST is an agency of the U.S. Commerce Department
Privacy policy / Security Notice / Accessibility Statement / Disclaimer / Freedom of Information Act (FOIA) /
No Fear Act Policy / NIST Information Quallity Standards / ExpectMore.gov (performance of federal programs)

Return to NIST Home Page
Return to ATP Home Page Return to NIST Home Page Go to the NIST Home Page